Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality

Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality

Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality

Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality

Synopsis

This title offers a broad perspective on institutional, political and supranational aspects of pharmaceutical regulation.

Excerpt

European national policy makers broadly agree on the core objectives that their health care systems should pursue. the list is strikingly straightforward: universal access for all citizens, effective care for better health outcomes, efficient use of resources, high-quality services and responsiveness to patient concerns. It is a formula that resonates across the political spectrum and which, in various, sometimes inventive configurations, has played a role in most recent European national election campaigns.

Yet this clear consensus can only be observed at the abstract policy level. Once decision makers seek to translate their objectives into the nuts and bolts of health system organization, common principles rapidly devolve into divergent, occasionally contradictory, approaches. This is, of course, not a new phenomenon in the health sector. Different nations, with different histories, cultures and political experiences, have long since constructed quite different institutional arrangements for funding and delivering health care services.

The diversity of health system configurations that has developed in response to broadly common objectives leads quite naturally to questions about the advantages and disadvantages inherent in different arrangements, and which approach is ‘better’ or even ‘best’ given a particular context and set of policy priorities. These concerns have intensified over the last decade as policy makers have sought to improve health system performance through what has become a European-wide wave of health system reforms. the search for comparative advantage has triggered – in health policy as in clinical medicine – increased attention to its knowledge base, and to the possibility of overcoming at least . . .

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.